Roche Molecular Diagnostics
http://molecular.roche.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Roche Molecular Diagnostics
Lilly Pre-Approval Spadework Includes Alzheimer’s Blood Test Development, Unbranded DTC Ads
Donanemab’s review delay will create more distance from Lilly’s direct-to-consumer advertising spotlighting its commitment to Alzheimer’s research. The company has also been supporting development of blood-based tools for early diagnoses, though they would not eliminate PET scans.
Lilly Pre-Approval Spadework Includes Alzheimer’s Blood Test Development, Unbranded DTC Ads
Lilly is supporting development of blood-based tools for early diagnose of Alzheimer's, but the delay of the review for donanemab will create more distance from Lilly’s direct-to-consumer advertising spotlighting its commitment to Alzheimer’s research.
FoundationOne Nabs US FDA Approval As Companion Diagnostic For Rare Cancers
The approval is the 25th indication for the diagnostic, but the first for any companion diagnostic to Roche’s Rozlytrek.
FDA: Roche Test Flaws Could Misdiagnose Patients With COVID-19, Flu
The US agency has contacted health care providers to warn them about faulty COBAS SARS-CoV-2 and Influenza A/B Nucleic Acid Tests for use on the COBAS Liat System.
Company Information
- Industry
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice